Applied Statistics

Cell Biology: Genentech

Total Score People Score Events Score
34 27 27
Date Event Presentation Speakers
May 23, 2014 Cellular Signalling and Cancer Therapy Tumor Suppressor role for the deubiquitinase, BAP1 Vishva Dixit
April 6, 2013 AACR Annual Meetings Expanding the Druggable Genome Chairperson: Stephen W. Fesik, Vanderbilt University School of Medicine, Nashville, TN Domagoj Vucic
Mitotic Checkpoints Driving Cancer Therapeutic Strategies Chairperson: Peter K. Jackson, Genentech, Inc., South San Francisco, CA Peter K Jackson
March 3, 2013 Understanding Dendritic Cell Biology to Advance Disease Therapies (C2) Harnessing DC Biology to Advance Disease Therapies Ira Mellman
Translating DC Biology into Medicine Ira Mellman
February 25, 2013 4th Cancer Targets and Therapeutics Targeting Inhibitor of Apoptosis (IAP) Proteins for Anti-cancer Therapies Domagoj Vucic
Opposing Effects of Androgen Deprivation and Targeted Therapy on Prostate Cancer Prevention Shidong Jia
February 3, 2013 Neurogenesis (J7) Neurobiology of Disease Ryan J. Watts, Marc Tessier Lavigne
February 3, 2013 New Frontiers in Neurodegenerative Disease Research (J8) Targeting Neurodegeneration by Boosting Antibody Uptake in Brain Ryan J. Watts
January 31, 2013 11th Cytokines and Inflammation Ubiquitination Regulates TNF Family Signaling Domagoj Vucic
November 29, 2011 The 7th annual European Antibody Congress is the worldleading conference addressing critical scientific issues and strategic industry challenges associated with therapeutic mAb development. Effects of molecular properties on antibody pharmacokinetics: recent lessons Saileta Prabhu
November 12, 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Concurrent Session 3 | Clinical development strategies of PI3K inhibitors Mika Derynck
July 10, 2011 Nutritional Immunology: Role in Health and Disease Obesity induced accelerated thymic aging Vishva Dixit
March 6, 2011 Stem Cells, Cancer and Metastasis (C4) Developmental Regulatory Pathways and Cancer Drug Discovery Frederic J. de Sauvage
February 12, 2011 Cancer Control by Tumor Suppressors and Immune Effectors (J8) Dendritic Cells (J7) | MHC Class II Pathways Ira Mellman
January 12, 2011 Antibodies for the 21st Century Endogenous Anti-IFNa Autoantibodies in Patients with Systemic Lupus Erythematosus are Associated with Decreased IFN-Pathway and Disease Activity Alyssa Morimoto
May 19, 2010 Towards Personalized Cancer Medicine Role of the Microenvironment in VEGF-Independent Angiogenesis Napoleone Ferrara
April 11, 2010 Synapses: Formation, Function and Misfunction (Z3) Synaptic Adhesion and Signaling | Ballroom 3 Robby M. Weimer
August 5, 2009 New Frontiers in Cancer Drug Development Cancer Stem Cells Chia Portera
Targeting the Hedgehog Pathway in Cancer Treatment Chia Portera
Bevacizumab in Patients with Previously Treated Glioblastoma Asha Das
June 9, 2009 RNAi for Target Identification and Validation Unlocking the Genome with Pooled shRNA Screens David P. Davis
June 8, 2009 The Business of Genomics Talk Title to be Announced Anna Williamson
January 6, 2009 Angiogenesis and Lymphangiogenesis in Cancer (A2) Emerging Targets and Endothelial Cell Biology Napoleone Ferrara
Notch Signaling Minhong Yan
November 11, 2008 3rd Annual European Post- Translational Modifications Improving the chemical stability of a therapeutic monoclonal antibody for aspartate isomerisation Jun Liu
Environmental effects on product quality: approaches to understanding and controlling glycosylation of recombinant proteins Martin Gawlitzek
May 30, 2008 ASCO Annual'08 Meeting professional development-- Contract Negotiations for Your First Job in Industry, Private Practice, or Academia Sean P. Bohen
April 28, 2008 Clinical Development of Therapeutic Antibodies The Development of Antiangiogenics in Lung Cancer Jane Huang
March 25, 2008 CYTOKINE-BASED THERAPEUTICS Preclinical Studies of Anti-OX40L in TH2-Driven Diseases Sarah Hymowitz
Title to Be Determined Vishva M. Dixit
February 10, 2008 GRC - Plasminogen Activation & Extracellular Proteolysis The transmembrane serine protease hepsin activates pro-hepatocyte growth factor (HGF) and pro-urokinase plasminogen activator (uPA) and promotes tumor progression Daniel Kirchhofer
February 7, 2008 Cell Death and Cellular Senescence Regulation of Apoptosis (Joint) Vishva M. Dixit
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 7: Anti-Cancer/Tumors Drug Discovery & Development and Current Status of the Innovative Therapeutics (Part II) (09:00-12:00) Mark S. Dennis
Session 7: Tumor Targeting with an AB.Fab (09:00-09:20) Mark S. Dennis
September 17, 2007 Optimizing Cell Culture Development (Sep17-18) Fractionation and Characterization of a Peptone Used in CHO Cell Culture Processes (14:30-15:00) Masaru Shiratori
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.